0001656472-21-000077.txt : 20210623 0001656472-21-000077.hdr.sgml : 20210623 20210623163642 ACCESSION NUMBER: 0001656472-21-000077 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210614 FILED AS OF DATE: 20210623 DATE AS OF CHANGE: 20210623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cortez Carlos S. CENTRAL INDEX KEY: 0001868992 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 211039090 MAIL ADDRESS: STREET 1: 111 PETER STREET, SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 3 1 wf-form3_162448058090841.xml FORM 3 X0206 3 2021-06-14 0 0001656472 Cronos Group Inc. CRON 0001868992 Cortez Carlos S. 111 PETER STREET, SUITE 300 TORONTO A6 M5V 2H1 ONTARIO, CANADA 0 1 0 0 VP, Controller No securities are beneficially owned. 0 D Exhibit List: Exhibit 24 - Power of Attorney /s/ Eileen Uy, as attorney-in-fact for Carlos S. Cortez 2021-06-23 EX-24 2 cronossection16authorizati.htm CSCPOA

Carlos S. Cortez  Exhibit 24


Authorization and Designation
to Sign and File
Section 16 Reporting Forms



    The undersigned does hereby authorize and designate each of Jerry Barbato, Xiu
Ming Shum and Eileen Uy, each with right to substitute and resubstitute, but for only so
long as each of them is an employee of Cronos Group Inc., a corporation incorporated
under the Business Corporations Act (British Columbia) (the "Company"), to sign and
file on his behalf the application for the required Securities and Exchange Commission
(the "SEC") electronic CIK/CCC codes and any and all Forms 3, 4 and 5 and Forms 144
relating to equity securities of the Company with the SEC pursuant to the requirements of
Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") and Rule
144 under the Securities Act of 1933, as amended.  This authorization, unless earlier
revoked in writing, shall be valid until the undersigned's reporting obligations under
Section 16 and Rule 144 with respect to equity securities of the Company shall cease.
All prior such authorizations are hereby revoked.

    IN WITNESS WHEREOF, the undersigned has executed this Authorization and
Designation this 15th day of June, 2021.




                             /s/ Carlos S. Cortez
                            Carlos S. Cortez